HEALTH● ELEVATED7h ago · Nov 2, 2026, 3:54 PM
United States approved the generic version of the injection to prevent HIV
Clarín · global
The FDA gave its approval for the development of lenacapavir, a treatment that costs 40 dollars a year. For specialists, it can be a key tool to reduce new infections and deaths in low-income countries.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH58m agoRussia’s HIV epidemic is worsening despite official claims to the contrary. Here’s what the numbers really show.Meduza [en]HEALTH3h agoEdwards Lifesciences says PASCAL beats medical therapy for tricuspid repairSeeking Alpha TechHEALTH3h agoFitness program cut transplant waitlist death risk by half, study findsThe HillHEALTH4h agoUS dairy worker dies from bird flu as outbreak rages in cattleThe Telegraph